OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $75,836 | -53.6% | 98,590 | +84.0% | 0.00% | – |
| Q1 2024 | $163,419 | -0.3% | 53,580 | +5.3% | 0.00% | – |
| Q4 2023 | $163,901 | -41.5% | 50,901 | -53.1% | 0.00% | – |
| Q1 2023 | $280,227 | +154.8% | 108,615 | +83.7% | 0.00% | – |
| Q4 2022 | $109,959 | +322.9% | 59,118 | +319.6% | 0.00% | – |
| Q3 2022 | $26,000 | +4.0% | 14,088 | +23.4% | 0.00% | – |
| Q2 2022 | $25,000 | -87.4% | 11,414 | -82.0% | 0.00% | – |
| Q1 2022 | $199,000 | -33.9% | 63,508 | -17.5% | 0.00% | – |
| Q2 2021 | $301,000 | +87.0% | 76,973 | +91.9% | 0.00% | – |
| Q1 2021 | $161,000 | -19.9% | 40,111 | +14.3% | 0.00% | – |
| Q3 2020 | $201,000 | -7.4% | 35,087 | +19.1% | 0.00% | – |
| Q2 2020 | $217,000 | +35.6% | 29,455 | -44.9% | 0.00% | – |
| Q1 2020 | $160,000 | +64.9% | 53,461 | +2.2% | 0.00% | – |
| Q2 2019 | $97,000 | +212.9% | 52,309 | +199.6% | 0.00% | – |
| Q1 2019 | $31,000 | – | 17,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,490,534 | $2,772 | 13.66% |
| Madison Avenue Partners, LP | 2,721,051 | $5,061,155 | 0.90% |
| Rubric Capital Management LP | 6,828,065 | $12,700,201 | 0.55% |
| BVF INC/IL | 6,851,051 | $12,742,955 | 0.54% |
| CHI Advisors LLC | 864,822 | $1,608,569 | 0.43% |
| EcoR1 Capital, LLC | 6,117,400 | $11,378,364 | 0.35% |
| Artal Group S.A. | 2,500,000 | $4,650 | 0.26% |
| Tejara Capital Ltd | 107,491 | $199,933 | 0.12% |
| Oasis Management Co Ltd. | 270,000 | $502,200 | 0.10% |
| DCF Advisers, LLC | 70,264 | $130,691 | 0.09% |